Mistletoe, a plant long revered in traditional medicine, has gained significant attention in modern integrative oncology. At ABNOBA GmbH, a research-based pharmaceutical company in Germany, mistletoe extracts are developed with scientific precision to provide supportive care for cancer patients. Through its Indian partner, ABNOBA India, these innovative therapies are now accessible for patients and healthcare professionals across the region.
What Are Mistletoe Extracts?
Mistletoe (Viscum album) is a semi-parasitic plant that grows on various trees. Extracts from this plant have been studied for decades for their potential in supporting cancer therapy. These extracts contain biologically active compounds such as lectins and viscotoxins, which are known to stimulate the immune system and may help improve the quality of life for cancer patients.
Benefits of Mistletoe Therapy
-
Immune Support: Enhances the body’s natural defense mechanisms.
-
Improved Tolerance to Treatment: Helps reduce side effects of chemotherapy and radiation.
-
Enhanced Quality of Life: Promotes better energy, sleep, and appetite in patients.
-
Holistic Approach: Complements conventional cancer treatments by addressing overall well-being.
Research-Driven Excellence
ABNOBA GmbH is committed to rigorous scientific research and clinical studies. With decades of expertise, the company ensures that every mistletoe extract product meets the highest safety and quality standards. ABNOBA’s work is deeply rooted in the philosophy of integrating nature and science to create effective therapeutic options.
ABNOBA India – Bringing Integrative Oncology Closer
Through ABNOBA India, patients and healthcare providers can access reliable mistletoe-based therapies. The goal is not only to provide treatment options but also to promote awareness about integrative cancer care in India.
✅ To learn more, visit: www.abnobaindia.com
